Warnex Medical Laboratories | GenomeWeb

Warnex Medical Laboratories

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Warnex announced that it has sold its medical laboratories division to Gamma-Dynacare Medical Laboratories for C$7.5 million (US$7.3 million).

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Warnex today said that it has signed an agreement to serve as exclusive distributor of 10 of DeCode Genetics' tests in Canada.

New Releases

Premium

Septin9 Colorectal Cancer Test

The company's Medical Laboratories testing and services division has received a renewal of its COLA accreditation.

So far this year, Rosetta has found commercialization partners for the diagnostics in the Middle East, Canada, the US, and India.

Warnex will market the tests and send tissue samples from its customers to Rosetta's Philadelphia-based lab for analysis.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.